Recently, coinciding with the opening of the annual meeting of the Orthopedics Branch of the Shanghai Medical Association,Medtronic Successfully Convenes the AiLLIANCE China Edition (hereinafter referred to as "ACE") Clinical Research Center Investigator Meeting in Shanghai, and Officially Announces the Full Launch of the Project in China.

As the first digital and intelligent orthopedic ecosystem clinical research project launched by Medtronic in China,The ACE study aims to explore Medtronic AiBLE™Intelligent Orthopedic EcosystemLocalization Applications and Value in China,While accelerating the digital and intelligent transformation in orthopedics, improving diagnostic and treatment levels, and enhancing medical accessibility, Medtronic (Shanghai) Limited, with Shanghai as a hub, is empowering the construction and upgrading of China's orthopedic digital and intelligent innovation ecosystem.

AiLLIANCE China Edition Clinical Research Project Launch Ceremony

During the "14th Five-Year Plan" period, Shanghai has listed biomedicine and artificial intelligence as key leading industries for development, focusing on building a globally influential science and technology innovation center. In constructing a highland for medical science and technology innovation, Shanghai continues to strengthen the allocation of innovative resources, forming an industrial ecosystem that integrates high-level clinical institutions, national translational medicine platforms, and cutting-edge technology companies, providing solid support for medical technology validation and achievement transformation.

Thanks to this advantage,ACE Clinical Research Project Lands in Shanghai. As a prospective cohort study, ACE will rely on four leading orthopedic research centers in China.Systematically evaluate the clinical value and health economics value of the digital intelligence orthopedic ecosystem, promoting the deep integration and large-scale application of intelligent technology in orthopedic clinics.In the future,ACELooking forward to driving technological iteration with clinical outcomes, starting from Shanghai, to promote the digital and intelligent upgrade of orthopedics across China, and to assist Shanghai in...“Orthopedic Technology High Ground”Towards“Orthopedic Innovation Hub”, and inject sustainable momentum into the development of the leading industry.

Spinal surgery, due to its involvement of complex neural tissues and critical anatomical structures, traditionally relies heavily on the surgeon's experience. However, with the acceleration of aging population, the continuous increase in the volume of spinal surgeries, and the growing complexity of disease diagnosis and treatment, clinical requirements for...The dual requirements for efficiency and precision are becoming increasingly urgent., which urgently needs technological innovation to achieve a breakthrough. Against this backdrop, the wave of digital intelligence is accelerating and sweeping through the medical industry, and orthopedics is also welcoming an opportunity for change in this process.——Represented by surgical robots and navigation systems, digital and intelligent technologies are continuously reshaping the spinal surgery model, driving diagnosis and treatment from "experience-dependent" towards a new phase of "data-driven" precision medicine.

As a global leader in medical technology innovation, Medtronic consistently focuses on the deep-seated clinical needs within the orthopedics field.In 2023, Medtronic introduced the AiBLE™ Intelligent Orthopedics Ecosystem concept, dedicated to bringing systematic innovation and providing solutions that align with transformative trends for orthopedics in China.TheThe solution will integrate intelligent devices such as surgical robots, navigation, intraoperative imaging, and power systems.With implants, deeply integrating artificial intelligence with data platforms,Actively ExploreDevice Interconnection and Data Interoperability.

Scientific Evidence-Based Approach is the Path to Medical InnovationClinicalA key link. Facing the digital and intelligent orthopedicsThe increasingly complex ecosystem and diverse technology combinations urgently require the dual validation of clinical and health economic value to drive and guide clinical applications.

ACE was launched against this backdrop, and the study will systematically evaluate AiBLE™ in Chinese patients through rigorous clinical research design.Effectiveness, Safety, Efficiency, Learning Curve, and Impact on Health Economics, providing a reference for clinical application.At the same time,Relying onMedtronicGlobal AiLLIANCE Research Project，ACEWill alsoBuildAriseA communication bridge between Chinese and foreign researchers, promoting the two-way exchange of clinical experience and research findings, and helping Chinese scholars make their voices heard more on the international academic stage.In the future, relying onData results accumulated from the ACE study are eagerly anticipated for AiBLE™.CanBetter assist surgery and serve patients.

“ACEThe launch is a crucial step towards the future development of orthopedics, and also marks the in-depth exploration of digital and intelligent transformation in clinical practice in China.” Vice President of Medtronic,General Manager of China Orthopedics and Neurosurgery BusinessYu Jing said，“We are honored to be in Shanghai, thisCombining bothA City with Excellent Medical Resources and Innovative Vitality, Joining HandsExcellentClinical CenterWith researchers,Jointly open thisProspectiveResearch. In the future, Medtronic will continue to leverage its advantages in intelligent technology and global experience, fully supporting...The advancement of the ACE project helps intelligent technology better serve clinical decision-making and hospital management, improving patient experience and optimizing medical efficiency. WeAlsoLooking forward to working with all parties through this collaboration to draw the future blueprint of orthopedic healthcare, and help build a smarter, more efficient, and sustainable healthcare ecosystem.。”